Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.

International journal of molecular sciences - 13 Feb 2020

D'Avanzo Francesca, Rigon Laura, Zanetti Alessandra, Tomanin Rosella

Abstract excerpt

Mucopolysaccharidosis type II (MPS II, Hunter syndrome) was first described by Dr. Charles Hunter in 1917. Since then, about one hundred years have passed and Hunter syndrome, although at first neglected for a few decades and afterwards mistaken for a long time for the similar disorder Hurler syndrome, has been clearly distinguished as a specific disease since 1978, when the distinct genetic causes of the two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain
Share to Carbohydrate Chemistry and Synthesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, X-Linked

Share to Iduronate Sulfatase

Share to Lysosomal Storage Disorders Research

Share to Mucopolysaccharidosis II

Share to Phenotype

Share to Trypanosoma species research and implications

Source

Open in PubMed Open full text

Identifiers

PMID: 32070051
DOI: 10.3390/ijms21041258
PMCID: PMC7072947

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.PMID 32070051Read ↗

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseSemantic proximity Read ↗

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.Semantic proximity Read ↗

Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease).Semantic proximity Read ↗

Mucopolysaccharidosis Type ISemantic proximity Read ↗

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and BeyondSemantic proximity Read ↗

Mucopolysaccharidosis III: Molecular basis and treatment.Semantic proximity Read ↗

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatmentSemantic proximity Read ↗

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Semantic proximity Read ↗

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?Semantic proximity Read ↗

A Review Of The Clinical Outcomes In Idursulfase-Treated And Untreated Filipino Patients With Mucopolysaccharidosis Type II: Data From The Local Lysosomal Storage Disease RegistrySemantic proximity Read ↗

The diagnosis and management of mucopolysaccharidosis type IISemantic proximity Read ↗

Mucopolysaccharidosis VII in Brazil: Natural History and Clinical FindingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.